Healthcare
PMV Pharmaceuticals, Inc.(PMVP)
Live Price
Offline$1.11
+1.83% today
1Y Change
-0.93%
Window
Jun 23, 2025 โ Jun 15, 2026
- Market Cap
- $70.00M
- Revenue Growth
- 0.0%
- EPS Growth
- -30.0%
- Dividend Yield
- 0.0%
Coverage: 246 bars ยท Jun 23, 2025 โ Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
PMV Pharmaceuticals, Inc. (PMVP) is a Healthcare stock with a market cap of $70.00M and listed on NASDAQ. The stock last traded around $1.11 and down 0.9% across the available one-year price window (Jun 23, 2025 โ Jun 15, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -30.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -30.0%, free cash flow -41.7% with operating margin 0.0% and ROIC -79.5%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines PMVP price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
0.0% vs +7.6% peer median
Operating Margin
Below sector median
0.0% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 8, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at 0.0% and EPS is at -30.0%, with operating margin around 0.0%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -5.9% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 8, 2026 | โ | -1.4% | -8.5% | -22.7% |
2026 Mar 6, 2026 | +15.0% | -0.6% | -4.9% | -20.7% |
2025 Nov 12, 2025 | +0.0% | -4.2% | -4.2% | -12.0% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PMVP
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
PMVP Max Drawdown
-41.67%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for PMVP and SPY.
Company Overview
PMV Pharmaceuticals, Inc.
NASDAQ Global Select
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing mutant p53 programs, including Wild-type p53 Induced-Phosphatase, R282W, and R273H, as well as other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey.
- Leadership
- David H. Mack
- IPO Date
- Sep 25, 2020
- Employees
- 47
- Street Address
- 8 Clarke Drive
- Mailing
- Princeton, NJ, 08512
- Region
- Princeton, NJ, US
- Reporting Currency
- USD
- Investor Line
- 609 642 6670
- Last Updated
- May 3, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- โ
- Price/Book
- 0.7
Growth
- Revenue
- 0.0%
- EPS
- -30.0%
- Free Cash Flow
- -41.7%
Profitability
- Gross Margin
- 0.0%
- Operating Margin
- 0.0%
- Net Margin
- 0.0%
- ROE
- -59.1%
- ROIC
- -79.5%
Balance Sheet
- Debt/Equity
- 0.01
- Current Ratio
- 10.09
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.